Cargando…

Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling

The occurrence of neuropsychiatric symptoms in the elderly is viewed as an early sign of subsequent cognitive deterioration and conversion from mild cognitive impairment to Alzheimer’s disease. The prognosis in terms of both the severity and progression of clinical dementia is generally aggravated b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutuli, Debora, Giacovazzo, Giacomo, Decandia, Davide, Coccurello, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750201/
https://www.ncbi.nlm.nih.gov/pubmed/36532180
http://dx.doi.org/10.3389/fpsyt.2022.1010169
_version_ 1784850202736197632
author Cutuli, Debora
Giacovazzo, Giacomo
Decandia, Davide
Coccurello, Roberto
author_facet Cutuli, Debora
Giacovazzo, Giacomo
Decandia, Davide
Coccurello, Roberto
author_sort Cutuli, Debora
collection PubMed
description The occurrence of neuropsychiatric symptoms in the elderly is viewed as an early sign of subsequent cognitive deterioration and conversion from mild cognitive impairment to Alzheimer’s disease. The prognosis in terms of both the severity and progression of clinical dementia is generally aggravated by the comorbidity of neuropsychiatric symptoms and decline in cognitive function. Undeniably, aging and in particular unhealthy aging, is a silent “engine of neuropathology” over which multiple changes take place, including drastic alterations of the gut microbial ecosystem. This narrative review evaluates the role of gut microbiota changes as a possible unifying concept through which the comorbidity of neuropsychiatric symptoms and Alzheimer’s disease can be considered. However, since the heterogeneity of neuropsychiatric symptoms, it is improbable to describe the same type of alterations in the bacteria population observed in patients with Alzheimer’s disease, as well as it is improbable that the variety of drugs used to treat neuropsychiatric symptoms might produce changes in gut bacterial diversity similar to that observed in the pathophysiology of Alzheimer’s disease. Depression seems to be another very intriguing exception, as it is one of the most frequent neuropsychiatric symptoms in dementia and a mood disorder frequently associated with brain aging. Antidepressants (i.e., serotonin reuptake inhibitors) or tryptophan dietary supplementation have been shown to reduce Amyloid β-loading, reinstate microbial diversity and reduce the abundance of bacterial taxa dominant in depression and Alzheimer’s disease. This review briefly examines this trajectory by discussing the dysfunction of gut microbiota composition, selected bacterial taxa, and alteration of tryptophan and serotonin metabolism/neurotransmission as overlapping in-common mechanisms involved with depression, Alzheimer’s disease, and unhealthy aging.
format Online
Article
Text
id pubmed-9750201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97502012022-12-15 Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling Cutuli, Debora Giacovazzo, Giacomo Decandia, Davide Coccurello, Roberto Front Psychiatry Psychiatry The occurrence of neuropsychiatric symptoms in the elderly is viewed as an early sign of subsequent cognitive deterioration and conversion from mild cognitive impairment to Alzheimer’s disease. The prognosis in terms of both the severity and progression of clinical dementia is generally aggravated by the comorbidity of neuropsychiatric symptoms and decline in cognitive function. Undeniably, aging and in particular unhealthy aging, is a silent “engine of neuropathology” over which multiple changes take place, including drastic alterations of the gut microbial ecosystem. This narrative review evaluates the role of gut microbiota changes as a possible unifying concept through which the comorbidity of neuropsychiatric symptoms and Alzheimer’s disease can be considered. However, since the heterogeneity of neuropsychiatric symptoms, it is improbable to describe the same type of alterations in the bacteria population observed in patients with Alzheimer’s disease, as well as it is improbable that the variety of drugs used to treat neuropsychiatric symptoms might produce changes in gut bacterial diversity similar to that observed in the pathophysiology of Alzheimer’s disease. Depression seems to be another very intriguing exception, as it is one of the most frequent neuropsychiatric symptoms in dementia and a mood disorder frequently associated with brain aging. Antidepressants (i.e., serotonin reuptake inhibitors) or tryptophan dietary supplementation have been shown to reduce Amyloid β-loading, reinstate microbial diversity and reduce the abundance of bacterial taxa dominant in depression and Alzheimer’s disease. This review briefly examines this trajectory by discussing the dysfunction of gut microbiota composition, selected bacterial taxa, and alteration of tryptophan and serotonin metabolism/neurotransmission as overlapping in-common mechanisms involved with depression, Alzheimer’s disease, and unhealthy aging. Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9750201/ /pubmed/36532180 http://dx.doi.org/10.3389/fpsyt.2022.1010169 Text en Copyright © 2022 Cutuli, Giacovazzo, Decandia and Coccurello. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Cutuli, Debora
Giacovazzo, Giacomo
Decandia, Davide
Coccurello, Roberto
Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title_full Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title_fullStr Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title_full_unstemmed Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title_short Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
title_sort alzheimer’s disease and depression in the elderly: a trajectory linking gut microbiota and serotonin signaling
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750201/
https://www.ncbi.nlm.nih.gov/pubmed/36532180
http://dx.doi.org/10.3389/fpsyt.2022.1010169
work_keys_str_mv AT cutulidebora alzheimersdiseaseanddepressionintheelderlyatrajectorylinkinggutmicrobiotaandserotoninsignaling
AT giacovazzogiacomo alzheimersdiseaseanddepressionintheelderlyatrajectorylinkinggutmicrobiotaandserotoninsignaling
AT decandiadavide alzheimersdiseaseanddepressionintheelderlyatrajectorylinkinggutmicrobiotaandserotoninsignaling
AT coccurelloroberto alzheimersdiseaseanddepressionintheelderlyatrajectorylinkinggutmicrobiotaandserotoninsignaling